 The study population consists of 100 participants with known clinically or serologically confirmed HIV infection. The participants, recruited by the staff of the Laboratory of Vial Diagnostics from the Evelyn Jordan Center, may be males or females including pregnant women at least 12 years of age from any ethnic and racial background. 